Drug pricing

News

Orchard’s MLD gene therapy becomes costliest US medicine

Orchard Therapeutics has revealed its US pricing plans for Lenmeldy, its gene therapy for metachromatic leukodystrophy (MLD), placing a $4.25 million price tag on the one-

News

Biden plan would axe interchangeable status for biosimilars

President Joe Biden’s budget proposal for fiscal 2025 includes a proposal that would allow pharmacy substitution of biosimilar drugs for the reference product, even if the

News

Pharma’s Medicare counteroffers are all in, says HHS

On the heels of a setback in pharma’s legal attempts to block Medicare’s new medicine price negotiation powers, the US government has said all drugmakers whose products ar

News

Judge knocks back AstraZeneca’s IRA challenge

AstraZeneca’s legal challenge to Medicare’s drug pricing negotiation powers has stumbled at the first hurdle in a federal court.

Market Access

Seizing the moment: The life sciences industry at the thresh...

The passage of the Inflation Reduction Act (IRA) signifies more than just a legislative milestone; it acts as a clarion call to the pharmaceutical industry.

News

White House wins in first Medicare negotiation legal ruling

A judge in a federal court in Texas has thrown out a lawsuit brought by the pharma industry challenging legislation introduced by the Biden administration that allows Medi

Orchard’s MLD gene therapy becomes costliest US medicine

Biden plan would axe interchangeable status for biosimilars

Pharma’s Medicare counteroffers are all in, says HHS

Judge knocks back AstraZeneca’s IRA challenge

Seizing the moment: The life sciences industry at the thresh...

White House wins in first Medicare negotiation legal ruling

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

Drug pricing

Editor's Picks